Clinical value of prognosis of serum prealbumin (PA)in patients with primary liver canc-er after TACE

Shasha Yu,Bo Pan,Yuyu Guo,Yongbin Meng,Zhe Chen,Xiaofeng Zhai
DOI: https://doi.org/10.3969/j.issn.1672-4992.2019.02.024
2019-01-01
Journal of Modern Oncology
Abstract:Objective:To determine the prognostic factors of patients with liver cancer TACE,and to explore the value of preoperative albumin content in evaluating the long-term prognosis of patients with liver cancer after TACE.Methods:Primary liver cancer patients and follow-up data in TCM Oncology Department of Shanghai Changhai Hos-pital were retrospectively analyzed in May 2012-November 2017 during liver surgery using single factor analysis and multifactor regression analysis to analyse preoperative clinical data of patients survival time.Results:A total of 342 patients with liver cancer with TACE were included in the study.Tumor size,TNM staging,preoperative PA level,and vascular invasion were independent risk factors for postoperative recurrence.The median survival time in the high PA group was 29.4 months,and the median survival time in the middle PA group was 16.8 months,and the median sur-vival time in the low PA group was 11.0 months,and the difference in the three groups was statistically significant.Conclusion:The low content of preoperative albumin PA was an independent risk factor for total survival of patients with liver cancer after TACE.
What problem does this paper attempt to address?